Search filters

List of works by Takahiro Nakayama

14-3-3σ expression is associated with poor pathological complete response to neoadjuvant chemotherapy in human breast cancers

scientific article published on 01 July 2012

A prospective feasibility study applying the ACOSOG Z0011 criteria to Japanese patients with early breast cancer undergoing breast-conserving surgery

scientific article published on 22 May 2018

Association between c-myc amplification and pathological complete response to neoadjuvant chemotherapy in breast cancer

scientific article published on July 7, 2011

Association of GSTP1 methylation with aggressive phenotype in ER-positive breast cancer

scientific article published in December 2013

Association of human epidermal growth factor receptor 2 status with ipsilateral breast tumor recurrence and resistance to endocrine therapy

scientific article published on 30 March 2015

Detection of aberrant promoter methylation of GSTP1, RASSF1A, and RARβ2 in serum DNA of patients with breast cancer by a newly established one-step methylation-specific PCR assay

scientific article published on May 19, 2011

Efficacy of Scalp Cooling in Preventing and Recovering From Chemotherapy-Induced Alopecia in Breast Cancer Patients: The HOPE Study

scientific article published on 06 August 2019

Estrogen receptor positive breast cancer identified by 95-gene classifier as at high risk for relapse shows better response to neoadjuvant chemotherapy

scientific article published on April 27, 2012

Evaluation of Trastuzumab Without Chemotherapy as a Post-operative Adjuvant Therapy in HER2-positive Elderly Breast Cancer Patients: Randomized Controlled Trial [RESPECT (N-SAS BC07)]

scientific article published on February 24, 2011

Factors associated with prolonged overall survival in patients with postmenopausal estrogen receptor-positive advanced breast cancer using real-world data: a follow-up analysis of the JBCRG-C06 Safari study

scientific article published on 06 December 2019

Factors associated with prolonged time to treatment failure with fulvestrant 500 mg in patients with post-menopausal estrogen receptor-positive advanced breast cancer: a sub-group analysis of the JBCRG-C06 Safari study.

scientific article published on 2 November 2017

First-line bevacizumab plus paclitaxel in Japanese patients with HER2-negative metastatic breast cancer: subgroup results from the randomized Phase III MERiDiAN trial.

scientific article published on 2 February 2017

Low dose capecitabine plus weekly paclitaxel in patients with metastatic breast cancer: a multicenter phase II study KBCSG-0609

scientific article published on January 20, 2013

Methylated DNA and Total DNA in Serum Detected by One-Step Methylation-Specific PCR Is Predictive of Poor Prognosis for Breast Cancer Patients

scientific article published on September 5, 2012

Phase I study of combination therapy with weekly paclitaxel and cyclophosphatamide for advanced or recurrent breast cancer.

scientific article

Phase II study of S-1 in combination with trastuzumab for HER2-positive metastatic breast cancer.

scientific article

Phase II study of bi-weekly irinotecan for patients with previously treated HER2-negative metastatic breast cancer: KMBOG0610B

scientific article published on November 29, 2011

Randomized phase II study of nab-paclitaxel as first-line chemotherapy in patients with HER2-negative metastatic breast cancer.

scientific article

Randomized phase II study of three doses of oral TAS‐108 in postmenopausal patients with metastatic breast cancer

scientific article published on July 16, 2012

Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil– epirubicin–cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to ne

scientific article

Regional lymphatic recurrence after salvage surgery for ipsilateral breast tumor recurrence of breast cancer without local treatment for regional lymphatic basin

scientific article published on 26 May 2014

Reliability of Estrogen Receptor and Human Epidermal Growth Factor Receptor 2 Expression on Breast Cancer Cells Stored in Cellprep® Vials

scientific article published on 31 October 2018

Safety for Repeat Lumpectomy Without Radiotherapy for Ipsilateral Breast Tumor Recurrence

scientific article published in September 2017

Safety of adjuvant trastuzumab for HER-2-overexpressing elderly breast cancer patients: a multicenter cohort study

scientific article published on April 28, 2011

Safety, pharmacokinetics and efficacy findings in an open-label, single-arm study of weekly paclitaxel plus lapatinib as first-line therapy for Japanese women with HER2-positive metastatic breast cancer

scientific article

Therapy options after CDK4/6 inhibitors for HR+, HER2- postmenopausal metastatic/recurrent breast cancer in Japan: a role for mammalian target of rapamycin inhibitors?

scientific article published on 02 July 2020

Transaxillary endoscopic partial mastectomy for comparatively early-stage breast cancer. An early experience

scientific article published on August 1, 1998

Treatment sequence of aromatase inhibitors and radiotherapy and long-term outcomes of breast cancer patients

scientific article published in August 2014

pTis and pT1a Ipsilateral Breast Tumor Recurrence Is Associated with Good Prognosis after Salvage Surgery

scientific article published on 11 October 2017